JEAN FRANCOIS FORMELA Insider Trading $SPRO Spero Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JEAN FRANCOIS FORMELA.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JEAN FRANCOIS FORMELA. JEAN FRANCOIS FORMELA is Director in Intellia Therapeutics, Inc. ($NTLA) and Director in Translate Bio, Inc. ($TBIO) and Director in Spero Therapeutics, Inc. ($SPRO) and Director in Ikena Oncology, Inc. ($IKNA).

Over the past year JEAN FRANCOIS FORMELA has been an insider in 3 companies. The total value of shares held by JEAN FRANCOIS FORMELA in these companies amounts to $10,175,843.

JEAN FRANCOIS FORMELA Director
Ikena Oncology, Inc.
Director
Intellia Therapeutics, Inc.
Director
Spero Therapeutics, Inc.
Director
Translate Bio, Inc.
$ 10175843 The total value of shares held by JEAN FRANCOIS FORMELA
Insider Rank

JEAN FRANCOIS FORMELA ranks 2,274 out of 350,000 insiders. Go to Insider Ranking to see more.

JEAN FRANCOIS FORMELA in Spero Therapeutics, Inc.

Trading Symbol: SPRO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEAN FRANCOIS FORMELA: Director
Holdings: 288,386 shares
Latest Transaction: Oct 27 2020

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 2,365,347
Shares Sold: 0
Share Difference: +2,365,347
Value Difference: -$5,999,994

Latest Insider Trading Transactions of JEAN FRANCOIS FORMELA in Spero Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, IKNA, NTLA, SPRO, TBIO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 27 2020SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseA13.527,500101,4007,500
Jan 06 2020SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseA9.875,40853,3775,408
Jun 05 2019SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseA10.676,07364,7996,073
Jun 06 2018SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseA11.546,07370,0826,073
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.003,662,17800
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.003,119,63300
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.001,250,00000
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.00982,90600
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorOption ExerciseC0.001,492,64500
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyP14.00428,5715,999,9942,408,1282 M to 2.4 M (+21.65 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00602,58901,979,5571.4 M to 2 M (+43.76 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00513,31801,376,968863.7 K to 1.4 M (+59.44 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00328,9920863,650534.7 K to 863.7 K (+61.53 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00246,2720534,658288.4 K to 534.7 K (+85.40 %)
Nov 07 2017SPROSpero Therapeutics ...FORMELA JEAN FRANCOISDirectorBuyC0.00245,6050288,38642.8 K to 288.4 K (+574.10 %)

Page:   1